CEO Linus Bosaeus and co-founder and CTO Dr. Lei Chen attended the European Society for Medical Oncology Congress 2022, to learn more about the latest advancements in Liquid Biopsy and Minimal Residual Disease and make new contacts in the field.
Dr. Lei Chen presented poster #629P; Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays – winning Best Poster Award 2022 at ESMO. The motivation by the scientific committee pointed out that the data provided new and valuable perspectives for monitoring of Leukemia patients, both clinically and for further research.
The Best Poster award means a lot, not only that the data and information holds high scientific relevance, but also that it was put together and presented in a structured and meaningful format.
Click on the image to see the poster.
